Medical News

News > Health > Medical News > J&J withdraws fibroid treatment device from market

J&J withdraws fibroid treatment device from market

WASHINGTON (AP) — Johnson & Johnson is asking surgeons not to use a line of devices for removing growths from the uterus amid regulators' growing concern that the electronic surgical tools raise the risk of spreading cancer to other parts of the body. In April, J&J suspended sales of the devices, known as laparoscopic power morcellators, after the Food and Drug Administration discouraged doctors from using them. Surgeons use the devices to treat painful fibroids, either by removing the growths themselves or the entire uterus. J&J said Wednesday it is conducting a worldwide withdrawal of all its morcellators still on the market. The company cited an FDA meeting earlier this month that reinforced "the complexity of this issue." FDA is weighing regulatory actions to reduce the risk of cancer spread.

Medical News

One type of cancer feared most by women is breast cancer, yet an Austin nurse says many of those fears are tied to...
NEW YORK (AP) — Individual Americans, rich or not, donated generously in response to many recent international...
DALLAS (AP) — Two nurses at Texas Health Presbyterian Hospital who cared for a Liberian patient with Ebola have...
DALLAS (AP) — A dated yearbook picture of a smiling young woman has become the latest face of Ebola in the U.S...
DALLAS (AP) — As Thomas Eric Duncan's health deteriorated, nurses Amber Joy Vinson and Nina Pham were at the Ebola...